Summary
8.09 0.47(6.17%)09/13/2024
Teladoc Inc (TDOC)
Teladoc Inc (TDOC)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 6.17 | 7.72 | 15.90 | -18.65 | -46.50 | -63.06 | -88.51 | -57.42 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 8.09 | |
| Open | 7.77 | |
| High | 8.14 | |
| Low | 7.75 | |
| Volume | 4,027,565 | |
| Change | 0.47 | |
| Change % | 6.17 | |
| Avg Volume (20 Days) | 4,590,441 | |
| Volume/Avg Volume (20 Days) Ratio | 0.88 | |
| 52 Week Range | 6.76 - 22.54 | |
| Price vs 52 Week High | -64.11% | |
| Price vs 52 Week Low | 19.67% | |
| Range | 4.12 | |
| Gap Up/Down | 0.07 | |
Fundamentals | ||
| Market Capitalization (Mln) | 1,385 | |
| EBIDTA | 46,215,000 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | -1.0100 | |
| WallStreet Target Price | 19.70 | |
| Book Value | 13.9570 | |
| Earnings Per Share | -1.3400 | |
| EPS Estimate Current Quarter | -0.2100 | |
| EPS Estimate Next Quarter | -0.4300 | |
| EPS Estimate Current Year | -1.0400 | |
| EPS Estimate Next Year | -0.6900 | |
| Diluted EPS (TTM) | -1.3400 | |
| Revenues | ||
| Profit Marging | -0.0847 | |
| Operating Marging (TTM) | -0.0453 | |
| Return on asset (TTM) | -0.0301 | |
| Return on equity (TTM) | -0.0951 | |
| Revenue TTM | 2,602,415,104 | |
| Revenue per share TTM | 15.8130 | |
| Quarterly Revenue Growth (YOY) | 0.0360 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | 1,662,853,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 357.1429 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 1.0343 | |
| Revenue Enterprise Value | 1.1046 | |
| EBITDA Enterprise Value | 18.6663 | |
| Shares | ||
| Shares Outstanding | 169,314,000 | |
| Shares Float | 165,553,990 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.14 | |
| Insider (%) | 0.77 | |
| Institutions (%) | 71.64 | |
09/15 06:59 EST - seekingalpha.com
Teladoc Health: Some Negative Things, But One Aspect That Makes Me Feel Positive
Teladoc's stock fell ~97% from its peak, but recent changes, including a new CEO, present a high-risk, high-reward opportunity. Positive year-over-year trends in integrated care members and chronic care enrollment, but effective monetization of these members remains a challenge. However, Teladoc's strong FCF and cheap valuation, trading at 4-5 times FCF, make it a potential turnaround candidate.
Teladoc Health: Some Negative Things, But One Aspect That Makes Me Feel Positive
Teladoc's stock fell ~97% from its peak, but recent changes, including a new CEO, present a high-risk, high-reward opportunity. Positive year-over-year trends in integrated care members and chronic care enrollment, but effective monetization of these members remains a challenge. However, Teladoc's strong FCF and cheap valuation, trading at 4-5 times FCF, make it a potential turnaround candidate.
09/10 19:21 EST - zacks.com
Why Teladoc (TDOC) Outpaced the Stock Market Today
Teladoc (TDOC) closed at $7.25 in the latest trading session, marking a +0.83% move from the prior day.
Why Teladoc (TDOC) Outpaced the Stock Market Today
Teladoc (TDOC) closed at $7.25 in the latest trading session, marking a +0.83% move from the prior day.
09/10 14:16 EST - zacks.com
Teladoc Stock Near 52-Week Low: Is it Healthy Enough to Invest?
TDOC is well positioned to grow in the long run on the back of expanding product offerings, memberships, AI integration, business diversification and global expansions.
Teladoc Stock Near 52-Week Low: Is it Healthy Enough to Invest?
TDOC is well positioned to grow in the long run on the back of expanding product offerings, memberships, AI integration, business diversification and global expansions.
09/06 16:30 EST - globenewswire.com
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
PURCHASE, NY, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued an inducement award to a new employee.
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
PURCHASE, NY, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued an inducement award to a new employee.
08/30 19:16 EST - zacks.com
Here's Why Teladoc (TDOC) Gained But Lagged the Market Today
In the closing of the recent trading day, Teladoc (TDOC) stood at $7.17, denoting a +0.99% change from the preceding trading day.
Here's Why Teladoc (TDOC) Gained But Lagged the Market Today
In the closing of the recent trading day, Teladoc (TDOC) stood at $7.17, denoting a +0.99% change from the preceding trading day.
08/20 18:12 EST - pymnts.com
Teladoc Health's New CEO Emphasizes Potential for Improvement Amid Mixed Results
Teladoc Health boasts substantial strengths and is positioned for enhanced performance, but according to new CEO Chuck Divita, there is work to do.
Teladoc Health's New CEO Emphasizes Potential for Improvement Amid Mixed Results
Teladoc Health boasts substantial strengths and is positioned for enhanced performance, but according to new CEO Chuck Divita, there is work to do.
08/18 07:03 EST - fool.com
Is There Any Hope for Teladoc Stock?
Teladoc's second-quarter financial results disappointed investors. The telemedicine company still has several things going its way.
Is There Any Hope for Teladoc Stock?
Teladoc's second-quarter financial results disappointed investors. The telemedicine company still has several things going its way.
08/05 15:33 EST - investorplace.com
3 Telemedicine Stocks Poised for Possible Healthcare Evolution
Telemedicine stocks could do no wrong during the pandemic. With millions on lockdown and still in need of medical care, telemedicine stocks, like Teledoc Health (NYSE:TDOC) ranfrom about $80 to a high of $288.80.
3 Telemedicine Stocks Poised for Possible Healthcare Evolution
Telemedicine stocks could do no wrong during the pandemic. With millions on lockdown and still in need of medical care, telemedicine stocks, like Teledoc Health (NYSE:TDOC) ranfrom about $80 to a high of $288.80.
08/04 10:00 EST - seekingalpha.com
Teladoc: Falling Knife Status Or Kitchen Sink Guidance?
Teladoc's new management has delivered a painful FQ2'24 earnings call, as observed in the BetterHelp impairment costs and withdrawn forward guidance. It is apparent that the telehealth company is facing growth issues and elevated marketing/advertising costs, with its near-term prospects likely to remain underwhelming. Readers must note the upcoming Livongo notes are likely to trigger further equity dilution, worsening the highly shorted stock's ongoing insider selling.
Teladoc: Falling Knife Status Or Kitchen Sink Guidance?
Teladoc's new management has delivered a painful FQ2'24 earnings call, as observed in the BetterHelp impairment costs and withdrawn forward guidance. It is apparent that the telehealth company is facing growth issues and elevated marketing/advertising costs, with its near-term prospects likely to remain underwhelming. Readers must note the upcoming Livongo notes are likely to trigger further equity dilution, worsening the highly shorted stock's ongoing insider selling.
08/02 14:15 EST - zacks.com
Teladoc Health (TDOC) Shares Down 8.9% Despite Q2 Earnings Beat
Teladoc Health (TDOC) expects revenue growth in the Integrated Care segment to be within low to mid-single-digit growth in 2024, on a year-over-year basis.
Teladoc Health (TDOC) Shares Down 8.9% Despite Q2 Earnings Beat
Teladoc Health (TDOC) expects revenue growth in the Integrated Care segment to be within low to mid-single-digit growth in 2024, on a year-over-year basis.
08/02 06:55 EST - investorplace.com
Get Your Money Out of These 3 Healthcare Stocks ASAP
In general, I'm quite bullish on the healthcare sector. Many of the names in the space have extremely low valuations because a high percentage of investors irrationally believed that healthcare companies could never perform well when interest rates were high.
Get Your Money Out of These 3 Healthcare Stocks ASAP
In general, I'm quite bullish on the healthcare sector. Many of the names in the space have extremely low valuations because a high percentage of investors irrationally believed that healthcare companies could never perform well when interest rates were high.
08/01 11:46 EST - seekingalpha.com
Teladoc Post Q2 Earnings: Stick A Fork In This Stock - It's Nearly Done (For)
Teladoc Health, Inc. stock has plummeted >95% since its peak in early 2021, with the downtrend near constant. Losses are usually exacerbated by quarterly earnings, and Q2 earnings, announced yesterday, were no exception. Teladoc's new CEO withdrew all guidance for 2024, signaling potential challenges ahead, especially with the BetterHelp segment facing high customer acquisition costs and churn.
Teladoc Post Q2 Earnings: Stick A Fork In This Stock - It's Nearly Done (For)
Teladoc Health, Inc. stock has plummeted >95% since its peak in early 2021, with the downtrend near constant. Losses are usually exacerbated by quarterly earnings, and Q2 earnings, announced yesterday, were no exception. Teladoc's new CEO withdrew all guidance for 2024, signaling potential challenges ahead, especially with the BetterHelp segment facing high customer acquisition costs and churn.
08/01 11:06 EST - reuters.com
Teladoc shares hit record low after telehealth firm withdraws 2024 forecast
Teladoc Health's shares hit a record low on Thursday, as surging costs and declining revenue in its mental health services unit forced the virtual healthcare provider to withdraw its annual and long-term forecasts.
Teladoc shares hit record low after telehealth firm withdraws 2024 forecast
Teladoc Health's shares hit a record low on Thursday, as surging costs and declining revenue in its mental health services unit forced the virtual healthcare provider to withdraw its annual and long-term forecasts.
08/01 10:36 EST - fool.com
Why Teladoc Stock Got Socked for a Loss Thursday
Teladoc reported a massive charge to earnings last night, and a huge earnings miss. The telemedicine company is still working through the consequences of its $18.5 billion purchase of Livongo four years ago.
Why Teladoc Stock Got Socked for a Loss Thursday
Teladoc reported a massive charge to earnings last night, and a huge earnings miss. The telemedicine company is still working through the consequences of its $18.5 billion purchase of Livongo four years ago.
08/01 06:00 EST - benzinga.com
Western Digital, Udemy, Teladoc Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Thursday.
Western Digital, Udemy, Teladoc Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Thursday.
07/31 20:00 EST - seekingalpha.com
Teladoc Health, Inc. (TDOC) Q2 2024 Earnings Call Transcript
Teladoc Health, Inc. (NYSE:TDOC ) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET Company Participants Chuck Divita - Chief Executive Officer Mala Murthy - Chief Financial Officer Michael Minchak - Head of Investor Relations Conference Call Participants Lisa Gill - J.P. Morgan Stephanie Davis - Barclays Jess Tassan - Piper Sandler Jailendra Singh - Truist Securities Richard Close - Cannacord Genuity Elizabeth Anderson - Evercore ISI Sarah James - Cantor Fitzgerald Sean Dodge - RBC Capital Markets Charles Rhyee - TD Cowen Michael Cherny - Leerink Partners Daniel Grosslight - Citi Operator Hello all, and welcome to Teladoc Health Second Quarter 2024 Earnings Call.
Teladoc Health, Inc. (TDOC) Q2 2024 Earnings Call Transcript
Teladoc Health, Inc. (NYSE:TDOC ) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET Company Participants Chuck Divita - Chief Executive Officer Mala Murthy - Chief Financial Officer Michael Minchak - Head of Investor Relations Conference Call Participants Lisa Gill - J.P. Morgan Stephanie Davis - Barclays Jess Tassan - Piper Sandler Jailendra Singh - Truist Securities Richard Close - Cannacord Genuity Elizabeth Anderson - Evercore ISI Sarah James - Cantor Fitzgerald Sean Dodge - RBC Capital Markets Charles Rhyee - TD Cowen Michael Cherny - Leerink Partners Daniel Grosslight - Citi Operator Hello all, and welcome to Teladoc Health Second Quarter 2024 Earnings Call.
07/31 19:01 EST - zacks.com
Teladoc (TDOC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Teladoc (TDOC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
07/31 18:30 EST - zacks.com
Teladoc (TDOC) Reports Q2 Loss, Misses Revenue Estimates
Teladoc (TDOC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.40 per share a year ago.
Teladoc (TDOC) Reports Q2 Loss, Misses Revenue Estimates
Teladoc (TDOC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.40 per share a year ago.
07/31 18:09 EST - marketwatch.com
Teladoc posts another quarterly loss, and online mental-health unit sees revenue slip
Shares of Teladoc Health Inc. fell more than 15% in the extended session Wednesday after the once high-flying telehealth company posted a much larger-than-expected quarterly loss and withdrew its guidance for the year.
Teladoc posts another quarterly loss, and online mental-health unit sees revenue slip
Shares of Teladoc Health Inc. fell more than 15% in the extended session Wednesday after the once high-flying telehealth company posted a much larger-than-expected quarterly loss and withdrew its guidance for the year.
07/31 16:44 EST - benzinga.com
Teladoc Stock Falls Below 52-Week Lows On Q2 Earnings: Guidance Withdrawn On BetterHealth Weakness, 'Focused On Addressing The Work Ahead Of Us With Urgency'
Telehealth company Teladoc Health Inc TDOC reported second-quarter financial results after market close Wednesday.
Teladoc Stock Falls Below 52-Week Lows On Q2 Earnings: Guidance Withdrawn On BetterHealth Weakness, 'Focused On Addressing The Work Ahead Of Us With Urgency'
Telehealth company Teladoc Health Inc TDOC reported second-quarter financial results after market close Wednesday.